Impact Factor 5.810 | CiteScore 6.2
More on impact ›
Submit your manuscript
Scope
The section “Gastrointestinal and Hepatic Pharmacology” welcomes articles concerned with the experimental and clinical pharmacology in the fields of the alimentary tract, the liver, biliary tree and pancreas.
Read More
Scope
The section “Gastrointestinal and Hepatic Pharmacology” welcomes articles concerned with the experimental and clinical pharmacology in the fields of the alimentary tract, the liver, biliary tree and pancreas. The manuscripts should have a direct bearing on the effect, mode of action or therapeutic use of drugs as well as on the identification of novel pharmacological targets. The definition of “drugs” will include existing drugs, compounds under development, naturally-occurring molecules, nutraceuticals, probiotics and standardized plant extracts (with the identification of the active ingredient(s) responsible for the pharmacological activity).
Topics range from – but are not limited to – cell growth and regeneration, immune system, motor function, fibrogenesis, carcinogenesis and secretion. Mechanisms which contribute to gastrointestinal sensations (such as taste, appetite, nausea and pain), acid secretion and gastrointestinal motility are also included. Review articles on potential targets and drug classes will be encouraged. All aspects of translation will be relevant, including comparisons between recombinant and native receptor functions, between animal and human biology, and between in vitro predictions and in vivo efficacy.
The mission is to be inclusive, and bring all relevant sub-specialties in pharmacology onto a single gastrointestinal-liver platform.
Indexed in: Chemical Abstracts Service (CAS), CrossRef, DOAJ, Google Scholar, PubMed, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE)
PMCID: all published articles receive a PMCID
Gastrointestinal and Hepatic Pharmacology welcomes submissions of the following article types: Brief Research Report, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Gastrointestinal and Hepatic Pharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41 (0)21 510 17 00
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41 (0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact pharmacology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact pharmacology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org